American Parkinson Disease Association

The World Parkinson Congress (WPC) gathers researchers, clinicians, and people living with Parkinson’s disease (PD) from around the world every three years. At the 7th WPC in Phoenix this May, several scientific themes surfaced again and again. Many questions remain open, but these themes show where PD research and care are headed. We’re sharing them for those who couldn...

A new treatment option for Parkinson’s disease (PD) just received approval. The US Food and Drug Administration (FDA) has approved JUVMO (tavapadon) for PD treatment in adults. The once-daily oral medication can be used either alone or alongside

When most people hear the phrase “Medicare payment policy,” their eyes glaze over. It sounds technical, bureaucratic, and far removed from daily life. But for people living with Parkinson’s disease (PD) and other chronic conditions, Medicare payment policy shapes whether care is available, affordable...

At the American Parkinson Disease Association (APDA), we know that some of the most powerful insights about Parkinson’s disease (PD) come from the people affected by it. Their perspectives – the challenges, victories, and hard-won wisdom – can be incredibly valuable to those on a similar path and others who want to learn more abou...